Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Do I Need a Covid-19 Vaccine Booster Shot?

06/11/2021 | 11:06am EDT

By WSJ Staff

Studies are under way exploring whether we will need to take booster shots to stay protected against Covid-19, and drugmakers are working on the shots. Here is what we know and don't know about the need for boosters.

Do I need a booster shot for my Covid-19 vaccine?

You probably will need a booster shot, though the matter is still under study. Though some vaccines, such as the one for measles, offer lifelong protection against a virus, other shots don't. The vaccine for tetanus and diphtheria requires a booster every 10 years, for instance, and women are supposed to get the whooping-cough vaccine each time they are pregnant, according to the Centers for Disease Control and Prevention's vaccine recommendations.

Many researchers suspect the immunity provided by Covid-19 vaccines will wane over time. They have that expectation partly because the natural immunity people develop against milder coronaviruses declines. "Historically, at least with the coronaviruses, the mild common cold coronaviruses, the durability of the protection from infection isn't very long," Anthony Fauci, director of the National Institute of Allergy and Infectious Disease, said at The Wall Street Journal's Tech Health conference in June. Another reason researchers say we will probably need a booster shot is to protect against any emerging coronavirus variants that are able to evade current vaccines.

When should I get a booster shot?

It may be every year, 18 months or even two years. It could be a different time frame. We really don't know yet. Whether and how often we would need to get a booster shot is under study right now. Remember, the Covid-19 vaccines haven't been around long, so not much time has passed to assess how long their protection lasts. In April, Pfizer Inc. released data indicating its vaccine remained effective six months after the second dose. Researchers can sort out how often we would need to get a booster shot after figuring how long the vaccines provide their fullest protection against Covid-19.

Is it safe for me to get a booster shot from a different vaccine brand?

That is under study right now. In June, NIAID, which is part of the National Institutes of Health, started a study looking at whether mixing and matching vaccines and boosters could prolong immunity and better protect against variants. One thing the study will explore is the best combination of shots. It may be that getting a vaccine from one manufacturer and a booster from another might actually produce stronger protection, researchers say. The ability to mix-and-match might also simplify the logistics of giving people boosters.

Will boosters better protect against coronavirus variants?

Researchers say the current vaccines appear to work well against variants of concern that have emerged so far. Yet they may not work as strongly against variants as they do against early strains. For that reason, we may want booster shots to ensure we get the fullest level of protection possible against the variants. And we would want booster shots if any variants emerge that prove better able to evade current vaccines. Drugmakers are working on shots targeting variants.

(END) Dow Jones Newswires

06-11-21 1105ET

All news about PFIZER, INC.
04:06aPFIZERá : Fact Check - Is There Lack of Storage Facilities for Covid-19 Vaccines..
06/24Bolsonaro says Brazil didn't spend a cent on Bharat vaccine deal under probe
06/24SANOFIá : Pfizer halts distribution of anti-smoking drug after finding carcinoge..
06/24Pfizer halts distribution of anti-smoking drug after finding carcinogen
06/24ASTRAZENECAá : Swiss health ministry data shows vaccinated people seldom hit by ..
06/24ASTRAZENECAá : EU slightly cuts estimates for vaccine deliveries this year
06/24WHO estimates COVID-19 boosters needed yearly for most vulnerable
06/24PFIZERá : First participant dosed in pfizer's pivotal phase 3 talapro-3 combinat..
06/24PFIZERá : Thinking about trading options or stock in Eli Lilly, Pfizer, Penn Nat..
06/24MARKET CHATTER : Pfizer, BioNTech COVID-19 Vaccine Found to be 90% Effective Aga..
More news
Financials (USD)
Sales 2021 72 838 M - -
Net income 2021 17 466 M - -
Net Debt 2021 26 268 M - -
P/E ratio 2021 13,3x
Yield 2021 4,02%
Capitalization 219 B 219 B -
EV / Sales 2021 3,37x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,2%
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 24
Last Close Price 39,19 $
Average target price 42,34 $
Spread / Average Target 8,04%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.6.47%218 590
JOHNSON & JOHNSON3.81%428 269
ROCHE HOLDING AG11.02%323 588
NOVARTIS AG1.71%207 904
ABBVIE INC.7.08%202 656